Contact us


St. Petersburg
in numbers
Foreign investors
in St. Petersburg


Swiss pharma giant Novartis (NOVN: VX) intends to localize production of up to 40 drugs at its Novartis-Neva plant in the Russian St Petersburg region, according to recent statements of vice governor of St Petersburg Sergey Movchan.
Grossman Group of companies from Germany is investing circa EUR 10 MM into production of innovative vacuum sewage equipment in Saint Petersburg, reported the Group's press function on Tuesday.
The Coca-Cola HBC Russia plant launched new juice production lines in Saint Petersburg. According to the Company’s press services, the investment in this project amounted to 170 billion rubles. The production lines of Dobry and Moya Semya juices will provide more than 145 million liters of juice per year and 30 additional jobs in the region, the press services added.
The Russian Direct Investment Fund (RDIF) and a unit of French public-sector lender Caisse des Depots are considering investing in French biotechnology company Olmix, the state Russian fund said on Tuesday. Investments could amount to up to 15 million euros ($17.70 million) and Olmix, a maker of algae-based products, would use the money to expand its production facilities in Russia’s second biggest city of St Petersburg, RDIF said.
Pharmaceutical and medical companies Novartis, Geropharm and Orion Medic intend to arrange commercial production of some of their medicines and equipment in Saint Petersburg by late 2017.
Hyundai Motor Company (HMG) can build their second plant for manufacture of car engines in Saint Petersburg. The negotiations on the possible construction were held in Korea, as reported by the press service of Vice-Governor Igor Albin.

Subscribe to Newsletters


Select a region